Vanderbilt University Medical Center

Medications

Drug modifies epigenome in aggressive brain tumors

A folic acid-like drug, L-methylfolate, when administered alongside the standard therapy for patients with recurrent glioblastoma, changed a DNA process within their brain tumors, according to results from a phase 1 clinical ...

page 8 from 40